Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_assertion type Assertion NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_head.
- NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_provenance.
- NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_assertion evidence source_evidence_literature NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_provenance.
- NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_assertion SIO_000772 23806066 NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_provenance.
- NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_assertion wasDerivedFrom befree-20140225 NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_provenance.
- NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_assertion wasGeneratedBy ECO_0000203 NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_provenance.